Prevalence of vitamin D deficiency in patients with inflammatory bowel disease

Prevalence of vitamin D deficiency in patients with inflammatory bowel disease - VITAceD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011185

Enrollment

200

Registered

2016-10-14

Start date

2017-06-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K50.9 K51.9

Interventions

Group 1: After informed consent, all patients will receive information material regarding vitamin D in the context of IBD. They will fill questionnaires regarding the history of their disease and curr

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients with confirmed diagnosis of IBD (Crohn's disease, ulcerative colitis, indeterminate colitis). - age >= 18 years

Exclusion criteria

Exclusion criteria: inability to consent

Design outcomes

Primary

Measure	Time frame
vitamin D serum concentration at baseline and after 6 (+/- 3 ) months	—

Secondary

Measure	Time frame
- IBD disease activity (as measured by Crohn's disease activity index [CDAI], Harvey Bradshaw index [HBI], colitis activity index [CAI]) as well as quality of life scores at baseline and during follow-up. - results of IBD-related blood tests collected at baseline and follow-up	—

Countries

Germany

Contacts

Public ContactChristine Janssen

Universitätsklinikum FreiburgKlinik für Innere Medizin II

christine.janssen@uniklinik-freiburg.de0761/27035400

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026